Emerging tropical diseases in Australia. Part 1. Leptospirosis

Suhella Tulsiani; C L Lau; G C Graham; A F Van Den Hurk; C C Jansen; L D Smythe; D B McKay; S B Craig

doi:10.1179/136485910x12851868779867

Emerging tropical diseases in Australia. Part 1. Leptospirosis

Suhella Tulsiani, C L Lau, G C Graham, A F Van Den Hurk, C C Jansen, L D Smythe, D B McKay, S B Craig

Global Health Section

16 Citations (Scopus)

Abstract

Human leptospirosis is a zoonotic disease of global importance that causes significant morbidity and mortality, particularly in developing nations. In this review, the history, epidemiology, transmission, clinical presentation and treatment of this disease, and its impact in Australia, are discussed. Central to this review is the delineation of diagnostic methods for the disease and the challenges that this disease presents for both the clinician and diagnostic laboratory. This information should furnish clinicians with an updated tool to help overcome a number of problems associated with the diagnosis of leptospirosis.

Original language	English
Journal	Pathogens and Global Health
Volume	104
Issue number	7
Pages (from-to)	543-56
Number of pages	14
ISSN	2047-7724
DOIs	https://doi.org/10.1179/136485910x12851868779867
Publication status	Published - 1 Oct 2010

Keywords

Anti-Bacterial Agents
Antibodies, Bacterial
Australia
Biological Markers
Communicable Diseases, Emerging
Enzyme-Linked Immunosorbent Assay
Humans
Leptospira
Leptospirosis
Polymerase Chain Reaction

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1179/136485910x12851868779867

Cite this

@article{5a9d2e175ac34fe9b5b36add6d9c5160,

title = "Emerging tropical diseases in Australia. Part 1. Leptospirosis",

abstract = "Human leptospirosis is a zoonotic disease of global importance that causes significant morbidity and mortality, particularly in developing nations. In this review, the history, epidemiology, transmission, clinical presentation and treatment of this disease, and its impact in Australia, are discussed. Central to this review is the delineation of diagnostic methods for the disease and the challenges that this disease presents for both the clinician and diagnostic laboratory. This information should furnish clinicians with an updated tool to help overcome a number of problems associated with the diagnosis of leptospirosis.",

keywords = "Anti-Bacterial Agents, Antibodies, Bacterial, Australia, Biological Markers, Communicable Diseases, Emerging, Enzyme-Linked Immunosorbent Assay, Humans, Leptospira, Leptospirosis, Polymerase Chain Reaction",

author = "Suhella Tulsiani and Lau, {C L} and Graham, {G C} and {Van Den Hurk}, {A F} and Jansen, {C C} and Smythe, {L D} and McKay, {D B} and Craig, {S B}",

year = "2010",

month = oct,

day = "1",

doi = "10.1179/136485910x12851868779867",

language = "English",

volume = "104",

pages = "543--56",

journal = "Pathogens and Global Health",

issn = "2047-7724",

publisher = "Taylor & Francis",

number = "7",

}

TY - JOUR

T1 - Emerging tropical diseases in Australia. Part 1. Leptospirosis

AU - Tulsiani, Suhella

AU - Lau, C L

AU - Graham, G C

AU - Van Den Hurk, A F

AU - Jansen, C C

AU - Smythe, L D

AU - McKay, D B

AU - Craig, S B

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Human leptospirosis is a zoonotic disease of global importance that causes significant morbidity and mortality, particularly in developing nations. In this review, the history, epidemiology, transmission, clinical presentation and treatment of this disease, and its impact in Australia, are discussed. Central to this review is the delineation of diagnostic methods for the disease and the challenges that this disease presents for both the clinician and diagnostic laboratory. This information should furnish clinicians with an updated tool to help overcome a number of problems associated with the diagnosis of leptospirosis.

AB - Human leptospirosis is a zoonotic disease of global importance that causes significant morbidity and mortality, particularly in developing nations. In this review, the history, epidemiology, transmission, clinical presentation and treatment of this disease, and its impact in Australia, are discussed. Central to this review is the delineation of diagnostic methods for the disease and the challenges that this disease presents for both the clinician and diagnostic laboratory. This information should furnish clinicians with an updated tool to help overcome a number of problems associated with the diagnosis of leptospirosis.

KW - Anti-Bacterial Agents

KW - Antibodies, Bacterial

KW - Australia

KW - Biological Markers

KW - Communicable Diseases, Emerging

KW - Enzyme-Linked Immunosorbent Assay

KW - Humans

KW - Leptospira

KW - Leptospirosis

KW - Polymerase Chain Reaction

U2 - 10.1179/136485910x12851868779867

DO - 10.1179/136485910x12851868779867

M3 - Journal article

C2 - 21092392

SN - 2047-7724

VL - 104

SP - 543

EP - 556

JO - Pathogens and Global Health

JF - Pathogens and Global Health

IS - 7

ER -

Emerging tropical diseases in Australia. Part 1. Leptospirosis

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this